Recently added

Pharmacological treatment in the FPI. Disease modifying drugs

Florenzano V., Matías; Reyes C., Felipe. Revista Chilena de Enfermedades Respiratorias; Vol. 35 No. 4 (2019): Chilean clinical practice guidelines for idiopathic pulmonary fibrosis, 2019; 287-292

Appendix 1

Unknown author. Revista Chilena de Enfermedades Respiratorias; Vol. 35 No. 4 (2019): Chilean clinical practice guidelines for idiopathic pulmonary fibrosis, 2019

2. Definition, pathogenesis and risk factors of idiopathic pulmonary fibrosis

Reyes C., Felipe. Revista Chilena de Enfermedades Respiratorias; Vol. 35 No. 4 (2019): Chilean clinical practice guidelines for idiopathic pulmonary fibrosis, 2019; 261-263

4. Differential diagnosis of idiopathic pulmonary fibrosis

Miranda S., Georgina; Salinas F., Mauricio. Revista Chilena de Enfermedades Respiratorias; Vol. 35 No. 4 (2019): Chilean clinical practice guidelines for idiopathic pulmonary fibrosis, 2019; 266-267

1. History and methodology of the first Chilean idiopathic pulmonary fibrosis guidelines, 2019

Florenzano V., Matías; Rodríguez C., Francisca. Revista Chilena de Enfermedades Respiratorias; Vol. 35 No. 4 (2019): Chilean clinical practice guidelines for idiopathic pulmonary fibrosis, 2019; 257-260

How is idiopathic pulmonary fibrosis suspected in primary health care?

Faba B., René; Tobar H., Ricardo; Glasinovic B., Valeska; Cerda C., Javier. Revista Chilena de Enfermedades Respiratorias; Vol. 35 No. 4 (2019): Chilean clinical practice guidelines for idiopathic pulmonary fibrosis, 2019; 264-265

Chilean clinical practice guidelines for idiopathic pulmonary fibrosis, 2019

Undurraga P., Álvaro. Revista Chilena de Enfermedades Respiratorias; Vol. 35 No. 4 (2019): Chilean clinical practice guidelines for idiopathic pulmonary fibrosis, 2019; 254-256

Heated tobacco products with special reference to IQOS

Bello S., Sergio. Revista Chilena de Enfermedades Respiratorias; Vol 35 No 3 (2019): Revista Chilena de Enfermedades Respiratorias; 225-231

Role of bacterial lysates in asthma, evidence and projection with special reference to OM-85

Zenteno A., Daniel; Díaz S., Javiera; Quezada L., Arnoldo. Revista Chilena de Enfermedades Respiratorias; Vol 35 No 3 (2019): Revista Chilena de Enfermedades Respiratorias; 219-224

N/A

Oyarzún Gómez, Manuel. Revista Chilena de Enfermedades Respiratorias; Vol 35 No 3 (2019): Revista Chilena de Enfermedades Respiratorias; 232-237

N/A

Astorga F., Luis. Revista Chilena de Enfermedades Respiratorias; Vol 35 No 3 (2019): Revista Chilena de Enfermedades Respiratorias; 237-240

Origin and natural history of asthma

Díaz Amor, Patricia. Revista Chilena de Enfermedades Respiratorias; Vol 35 No 3 (2019): Revista Chilena de Enfermedades Respiratorias; 169-172

Crazy paving computed tomography pattern in a young woman. Unexpected findings and non-traditional treatment in a pulmonary alveolar proteinosis case

Rioseco S., Patricio; Muñoz V., Susana; Vivaldi B., Camila; Fuica de la V., Andrés; Bari T., Carmen. Revista Chilena de Enfermedades Respiratorias; Vol 35 No 3 (2019): Revista Chilena de Enfermedades Respiratorias; 199-206

Comparative study of the categorization of COPD patients based on GOLD 2007, 2011 and 2019

Santeliz C., Joanna. Revista Chilena de Enfermedades Respiratorias; Vol 35 No 3 (2019): Revista Chilena de Enfermedades Respiratorias; 173-180

Invasive pulmonary aspergillosis in rheumatological patients. Presentation of two cases

Maldonado O., Lorena; Albuja A., Evelyn; Reyes H., Mirtha; Barros M., Manuel; Cartagena S., Claudia; Cruz Ch., Rodrigo. Revista Chilena de Enfermedades Respiratorias; Vol 35 No 3 (2019): Revista Chilena de Enfermedades Respiratorias; 191-198

Impact of pollution by particulate matter on emergency room admissions for respiratory causes in Chillán, Concepción, and Los Ángeles, Chile

Remaggi S., Jonnthan; Mardones P., Cristián; Jiménez R., Jorge. Revista Chilena de Enfermedades Respiratorias; Vol 35 No 3 (2019): Revista Chilena de Enfermedades Respiratorias; 181-190

Sociedad Chilena de Enfermedades Respiratorias: Recent submissions

Pharmacological treatment in the FPI. Disease modifying drugs

Appendix 1

2. Definition, pathogenesis and risk factors of idiopathic pulmonary fibrosis

4. Differential diagnosis of idiopathic pulmonary fibrosis

1. History and methodology of the first Chilean idiopathic pulmonary fibrosis guidelines, 2019

How is idiopathic pulmonary fibrosis suspected in primary health care?

Chilean clinical practice guidelines for idiopathic pulmonary fibrosis, 2019

Heated tobacco products with special reference to IQOS

Role of bacterial lysates in asthma, evidence and projection with special reference to OM-85

N/A

N/A

Origin and natural history of asthma

Crazy paving computed tomography pattern in a young woman. Unexpected findings and non-traditional treatment in a pulmonary alveolar proteinosis case

Comparative study of the categorization of COPD patients based on GOLD 2007, 2011 and 2019

Invasive pulmonary aspergillosis in rheumatological patients. Presentation of two cases

Impact of pollution by particulate matter on emergency room admissions for respiratory causes in Chillán, Concepción, and Los Ángeles, Chile

N/A

N/A

Pulmonary lymphangioleiomyomatosis, a rare lung disease: presentation of a clinical case

Epidemiological situation of tuberculosis in Chile, 2018

Sociedad Chilena de Enfermedades Respiratorias: Recent submissions

Pharmacological treatment in the FPI. Disease modifying drugs ﻿

Appendix 1 ﻿

2. Definition, pathogenesis and risk factors of idiopathic pulmonary fibrosis ﻿

4. Differential diagnosis of idiopathic pulmonary fibrosis ﻿

1. History and methodology of the first Chilean idiopathic pulmonary fibrosis guidelines, 2019 ﻿

How is idiopathic pulmonary fibrosis suspected in primary health care? ﻿

Chilean clinical practice guidelines for idiopathic pulmonary fibrosis, 2019 ﻿

Heated tobacco products with special reference to IQOS ﻿

Role of bacterial lysates in asthma, evidence and projection with special reference to OM-85 ﻿

N/A ﻿

N/A ﻿

Origin and natural history of asthma ﻿

Crazy paving computed tomography pattern in a young woman. Unexpected findings and non-traditional treatment in a pulmonary alveolar proteinosis case ﻿

Comparative study of the categorization of COPD patients based on GOLD 2007, 2011 and 2019 ﻿

Invasive pulmonary aspergillosis in rheumatological patients. Presentation of two cases ﻿

Impact of pollution by particulate matter on emergency room admissions for respiratory causes in Chillán, Concepción, and Los Ángeles, Chile ﻿

N/A ﻿

N/A ﻿

Pulmonary lymphangioleiomyomatosis, a rare lung disease: presentation of a clinical case ﻿

Epidemiological situation of tuberculosis in Chile, 2018 ﻿

Pharmacological treatment in the FPI. Disease modifying drugs

Appendix 1

2. Definition, pathogenesis and risk factors of idiopathic pulmonary fibrosis

4. Differential diagnosis of idiopathic pulmonary fibrosis

1. History and methodology of the first Chilean idiopathic pulmonary fibrosis guidelines, 2019

How is idiopathic pulmonary fibrosis suspected in primary health care?

Chilean clinical practice guidelines for idiopathic pulmonary fibrosis, 2019

Heated tobacco products with special reference to IQOS

Role of bacterial lysates in asthma, evidence and projection with special reference to OM-85

N/A

N/A

Origin and natural history of asthma

Crazy paving computed tomography pattern in a young woman. Unexpected findings and non-traditional treatment in a pulmonary alveolar proteinosis case

Comparative study of the categorization of COPD patients based on GOLD 2007, 2011 and 2019

Invasive pulmonary aspergillosis in rheumatological patients. Presentation of two cases

Impact of pollution by particulate matter on emergency room admissions for respiratory causes in Chillán, Concepción, and Los Ángeles, Chile

N/A

N/A

Pulmonary lymphangioleiomyomatosis, a rare lung disease: presentation of a clinical case

Epidemiological situation of tuberculosis in Chile, 2018